Activation of NF-κB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells

被引:279
作者
Li, JD
Feng, WJ
Gallup, M
Kim, JH
Gum, J
Kim, Y
Basbaum, C
机构
[1] Univ Calif San Francisco, Dept Anat, Program Biomed Sci, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Metab Res Unit, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[5] Univ Calif San Francisco, Vet Adm Med Ctr, San Francisco, CA 94143 USA
关键词
D O I
10.1073/pnas.95.10.5718
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cystic fibrosis (CF) is an autosomal recessive disorder, the most common lethal genetic disease in Caucasians, Respiratory disease is the major cause of morbidity and mortality. Indeed, 95% of CF patients die of respiratory failure. Pseudomonas aeruginosa, an opportunistic pathogen, chronically infects the lungs of over 85% of CF patients. it is ineradicable by antibiotics and responsible for airway mucus overproduction that contributes to airway obstruction and death. The molecular mechanisms underlying this pathology are unknown. Here we show that P. aeruginosa activates a c-Src-Ras-MEK1/2-MAPK-pp90rsk signaling pathway that leads to activation of nuclear factor NF-kappa B (p65/D50). Activated NF-kappa B binds to a kappa B site in the 5'-flanking region of the MUC2 gene and activates MUC2 mucin transcription. These studies bring new insight into bacterial-epithelial interactions and more specifically into the molecular pathogenesis of cystic fibrosis, Understanding these signaling and gene regulatory mechanisms opens up new therapeutic targets for cystic fibrosis.
引用
收藏
页码:5718 / 5723
页数:6
相关论文
共 30 条
[1]  
ALESS DR, 1993, J BIOL CHEM, V270, P27489
[2]   NF-kappa B: Ten years after [J].
Baeuerle, PA ;
Baltimore, D .
CELL, 1996, 87 (01) :13-20
[3]   The NF-kappa B and I kappa B proteins: New discoveries and insights [J].
Baldwin, AS .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :649-683
[4]   Transdominant mutants of I kappa B alpha block Tat tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication [J].
Beauparlant, P ;
Kwon, H ;
Clarke, M ;
Lin, RT ;
Sonenberg, N ;
Wainberg, M ;
Hiscott, J .
JOURNAL OF VIROLOGY, 1996, 70 (09) :5777-5785
[5]   CYSTIC-FIBROSIS - A WELCOME ANIMAL-MODEL [J].
COLLINS, FS ;
WILSON, JM .
NATURE, 1992, 358 (6389) :708-709
[6]   LUNG-DISEASE IN THE CYSTIC-FIBROSIS MOUSE EXPOSED TO BACTERIAL PATHOGENS [J].
DAVIDSON, DJ ;
DORIN, JR ;
MCLACHLAN, G ;
RANALDI, V ;
LAMB, D ;
DOHERTY, C ;
GOVAN, J ;
PORTEOUS, DJ .
NATURE GENETICS, 1995, 9 (04) :351-357
[7]   A cytokine-responsive I kappa B kinase that activates the transcription factor NF-kappa B [J].
DiDonato, JA ;
Hayakawa, M ;
Rothwarf, DM ;
Zandi, E ;
Karin, M .
NATURE, 1997, 388 (6642) :548-554
[8]   RELATIONSHIP AMONG GUANINE-NUCLEOTIDE EXCHANGE, GTP HYDROLYSIS, AND TRANSFORMING POTENTIAL OF MUTATED RAS PROTEINS [J].
FEIG, LA ;
COOPER, GM .
MOLECULAR AND CELLULAR BIOLOGY, 1988, 8 (06) :2472-2478
[9]   The 90-kDa ribosomal S6 kinase (pp90(rsk)) phosphorylates the N-terminal regulatory domain of I kappa B alpha and stimulates its degradation in vitro [J].
Ghoda, L ;
Lin, X ;
Greene, WC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (34) :21281-21288
[10]   Identification and characterization of the MUC2 (human intestinal mucin) gene 5'-flanking region: Promoter activity in cultured cells [J].
Gum, JR ;
Hicks, JW ;
Kim, YS .
BIOCHEMICAL JOURNAL, 1997, 325 :259-267